How Will the Market React to Opko Health Inc. (OPK) Stock Getting a Neutral Rating

Opko Health Inc. (OPK) stock has fallen 7.61% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

Opko Health Inc. has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on OPK!

See Full OPK Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With OPK Stock Today?

Opko Health Inc. (OPK) stock is trading at $1.82 as of 3:48 PM on Monday, Sep 26, a decline of -$0.06, or -3.46% from the previous closing price of $1.88. The stock has traded between $1.78 and $1.90 so far today. Volume today is light. So far 1,559,970 shares have traded compared to average volume of 2,783,623 shares.

More About Opko Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs. Click Here to get the full Stock Report for Opko Health Inc. stock.